The End of Trial and Error.
End-to-end drug effect simulation. From molecule to market, predicted before a single patient enrolls.
Virtual Clinical Trials
Our simulation engine models full drug effect chains across PGx, PK, PD, toxicity, biomarkers, pathways, DDI and disease progression. It combines AI with mechanistic simulation where every output traces directly back to its inputs. Validated against 250+ clinical trials across neurology, oncology, cardiology, psychiatry, metabolic, infectious and rare diseases. From precision medicine to population-scale predictions, in a fraction of the time and cost of conventional trials.
AI Drug Discovery
The same environment powers an end-to-end discovery pipeline. Optimize existing treatments, identify novel molecules and generate candidate compounds, then run them through our full simulation chain and validate against real clinical scenarios. Built by a team with 30+ years in pharmacology and over a decade in software engineering. We're actively seeking co-development partners in BioTech, Pharma and CROs to push this further together.